CymaBay Therapeutics Inc. (CBAY) declined -9.52% or -1.0 to $9.5. It is near 2.76 million shares traded, which is 580.9% compare to the average total volume 475656. The market cap of CBAY is $564.67 million. The year to date change is 7.14%. The 52 week price range is from $7.37 to $15.59. Price of CBAY have changed -3.76% during last week. It have changed 3.75% over last month, -13.65% over last 3 months, -10.03% over last 6 months and 24.93% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CBAY is 11.25. It is 18.42% above current price. The 200-day Moving Averages for CBAY is 12.38. It is 30.32% above current price. The 52-week High is 15.59. It is 64.11% from the current price. The 52-week Low is 7.37. It is -22.42% from current price.
There are some statistics of CBAY. It is has market cap $564.67 million. The share outstanding is 59.44 million. The average volume is 475656. The percent of top 15 Institution holding is 39.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CBAY is -42.34%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CBAY is -37.75%.